Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |